Genetics of graft-versus-host disease, I. A locus on Chromosome 1 influences development of acute graft-versus-host disease in a major histocompatibility complex mismatched murine model

被引:0
作者
Allen, RD [1 ]
Dobkins, JA [1 ]
Harper, JM [1 ]
Slayback, DL [1 ]
机构
[1] Indiana Univ Purdue Univ, Dept Biol, Indianapolis, IN 46202 USA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Graft-versus-host disease (GVHD) is the major complication occurring after bone marrow transplantation. The severity of GVHD varies widely, with this variation generally being attributed to variation in the degree of disparity between host and donor for minor histocompatibility antigens. However, it is also possible that other forms of polymorphism, such as polymorphisms in immune effector molecules, might play a significant role in determining GVHD severity. In order to investigate this hypothesis, we are studying the genetic factors that influence GVHD development in a murine model. We here report the first results of this analysis, which demonstrate that a locus on Chromosome 1 of the mouse, and possibly also a locus on Chromosome 4, exert considerable influence over the development of one aspect of acute GVHD-splenomegaly-in a parent-->F-1 murine model. These results demonstrate that non-MHC genes can exert quite significant effects on the development of GVHD-associated pathology and that gene mapping can be used as a tool to identify these loci. Further analysis of such loci will allow identification of the mechanism whereby they influence GVHD and may lead in the future to improved selection of donors for human bone marrow transplantation.
引用
收藏
页码:254 / 261
页数:8
相关论文
共 35 条
[1]   DIFFERENTIAL CYTOKINE EXPRESSION IN ACUTE AND CHRONIC MURINE GRAFT-VERSUS-HOST-DISEASE [J].
ALLEN, RD ;
STALEY, TA ;
SIDMAN, CL .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (02) :333-337
[2]   GENETIC-POLYMORPHISM OF HUMAN INTERLEUKIN-1-ALPHA [J].
BAILLY, S ;
DIGIOVINE, FS ;
BLAKEMORE, AIF ;
DUFF, GW .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (06) :1240-1245
[3]   Distinct regulatory roles of lymphocyte costimulatory pathways on T helper type 2-mediated autoimmune disease [J].
Biancone, L ;
Andres, G ;
Ahn, H ;
Lim, A ;
Dai, C ;
Noelle, R ;
Yagita, H ;
DeMartino, C ;
Stamenkovic, I .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (04) :1473-1481
[4]  
BIOQUE G, 1995, CLIN EXP IMMUNOL, V102, P379
[5]  
Blakemore AIF, 1996, HUM GENET, V97, P369, DOI 10.1007/BF02185776
[6]   EVIDENCE FOR AN ENDOGENOUS SUPERANTIGEN DELETING HUMAN V-BETA-2 POSITIVE T-LYMPHOCYTES [J].
BOYLSTON, AW ;
CLARKE, GR ;
LANCASTER, FC ;
REYBURN, H .
T-CELL RECEPTOR USE IN HUMAN AUTOIMMUNE DISEASES, 1995, 756 :113-116
[7]  
CHURCHILL GA, 1994, GENETICS, V138, P963
[8]   A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes [J].
Conrad, B ;
Weissmahr, RN ;
Boni, J ;
Arcari, R ;
Schupbach, J ;
Mach, B .
CELL, 1997, 90 (02) :303-313
[9]   CD30-MEDIATED SIGNALING PROMOTES THE DEVELOPMENT OF HUMAN T-HELPER TYPE 2-LIKE T-CELLS [J].
DELPRETE, G ;
DECARLI, M ;
DELIOS, MM ;
DANIEL, KC ;
ALMERIGOGNA, F ;
ALDERSON, M ;
SMITH, CA ;
THOMAS, E ;
ROMAGNANI, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (06) :1655-1661
[10]  
DEWIT D, 1993, J IMMUNOL, V150, P361